Unlock opportunities to accelerate your health innovations in the world’s largest emerging pharmaceutical market!

Austrade invites Australian businesses involved in research and innovation across the life sciences, medical, and pharmaceutical sectors to join the 2018 Life Sciences Mission to China.

Mission highlights include attending the China BioMed Innovation and Investment Conference 2018, visiting Suzhou BioBay, and attending a Clinical Trials Seminar with Zhongguancun Life Science Park in Beijing. There will be valuable opportunities to build connections with key customers and contacts, gain insights from senior company and regulatory representatives across the Chinese health sector, and promote Australian health capabilities to over 2,000 conference attendees.

Identified by President Xi Jinping as a growth area in his “Made in China 2025” Plan, China possesses the second largest pharmaceutical market worldwide. Ongoing regulatory reform of the State Drug Administration (SDA), supportive R&D infrastructure, and growing biotechnology and medical innovation and investment have seen China emerge as a prime market for pharmaceutical and healthcare companies.

• Date
    17-21 September 2018

• Location(s)
    China: Suzhou/Beijing (Optional)

• Apply by
    Friday 3 August 2018

Australian businesses driving innovation across:

• medical technologies
  

• pharmaceuticals

• medical devices

• research and development organisations.

• China Pharmaceutical Innovation and Research Development Association (PhIRDA)

• China Association for Medical Devices Industry (CAMDI)

• China BioMed Innovation Investment Conference (CBIIC)

• Suzhou Biobay

• Zhongguancun Life Science Park, Beijing

  
  

• Advance your connections with potential customers and contacts through networking and tailored one-on-one business matching meetings.

• Capitalise on the opportunity to increase awareness of your brand and IP.

• Gain insights from senior representatives from SDA, China Health Commission, J.P. Morgan, Security Association of China (SAC) about their objectives and future business plans.

• Enhance your understanding of market trends and opportunities by leading pharma and biotech companies in China.

• Accomplish your goals with on-the-ground assistance from Austrade and advice on how to successfully operate in China.

In order to provide the highest level of service to delegates, places are strictly limited.

For more details about this mission and reservation please visit www.austrade.gov.au/lifescienceschina (or click Read More) to have our country and industry specialists review your application. If your application is successful we will send you an acceptance letter with our standard terms and conditions and an invoice for payment. An Event Participation Kit with all the information you need to prepare for the  mission will then be sent to you.